Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 known ✓ | P00918 | 1/20 | 0.39 |
| ▸ | THRB known ✓ | P10828 | 1/20 | 0.39 |
| ▸ | RECQL | P46063 | 2/20 | 0.40 |
| ▸ | CES2 | O00748 | 1/20 | 0.40 |
| ▸ | GLA | P06280 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.40 |
| ▸ | BLM | P54132 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | CPT2 | P23786 | 1/20 | 0.37 |
| ▸ | CPT1A | P50416 | 1/20 | 0.37 |
| ▸ | CPT1B | Q92523 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31402373 | 1.00 | RECQL (0.40) | RECQLCES2GLAHPGDTSHR | |
| SCHEMBL28690849 | 1.00 | RECQL (0.40) | RECQLCES2GLAHPGDTSHR | |
| SCHEMBL28709042 | 1.00 | RECQL (0.40) | RECQLCES2GLAHPGDTSHR | |
| SCHEMBL28690847 | 1.00 | RECQL (0.40) | RECQLCES2GLAHPGDTSHR | |
| SCHEMBL2726851 | 0.99 | MEN1 (0.41) | RECQLCES2GLAHPGDTSHR | |
| SCHEMBL8000985 | 0.99 | RECQL (0.39) | RECQLCES2GLAHPGDTSHR | |
| Phosphoric Acid SCHEMBL28320584 | 0.95 | LPAR5 (0.39) | RECQLCES2GLAHPGDTSHR | |
| SCHEMBL28664374 | 0.92 | EPHX2 (0.47) | EPHX2 | |
| Dodecane SCHEMBL27642194 | 0.91 | CA2 (0.46) | EPHX2CA2CPT2CPT1ACPT1B | |
| Octane SCHEMBL28131914 | 0.91 | CA2 (0.46) | EPHX2CA2CPT2CPT1ACPT1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1100 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110325171-B | Skin and hand cleaning compositions comprising brushing material | 德比IP有限公司 | 2024-06-28 | — | — | CN | claimed |
| CN-117024781-A | Nanocellulose composite conductive lubricating hydrogel and preparation method thereof | 季华实验室 | 2023-11-10 | — | — | CN | claimed |
| US-20230329232-A1 | Low Viscosity Agricultural Adjuvant for Spraying Syrups and Method of Production | Forquimica Agrociencia Ltda (BR) | 2023-10-19 | — | — | US | claimed |
| EP-4204100-A1 | HAIR LIGHTENING COMPOSITIONS PROVIDING DAMAGE PROTECTION AND SENSORIAL BENEFITS AND METHODS OF USE | L'OREAL (FR) | 2023-07-05 | — | — | EP | claimed |
| CN-116322616-A | Hair lightening compositions providing damage protection and sensory benefits and methods of use | 欧莱雅 | 2023-06-23 | — | — | CN | claimed |
| CN-112654246-B | Herbicidal compositions with improved properties | 拜耳公司 | 2023-01-03 | — | — | CN | claimed |
| US-11382844-B2 | Shampoo composition and method of use | CONOPCO, INC. (US) | 2022-07-12 | — | — | US | claimed |
| US-11376209-B2 | Antidandruff composition and method of use | CONOPCO, INC. (US) | 2022-07-05 | — | — | US | claimed |
| CN-114617801-A | Formula and processing method of peony seed oil skin-moistening hand sanitizer | 徐波 | 2022-06-14 | — | — | CN | claimed |
| US-11260008-B2 | Hair treatment composition | CONOPCO, INC. (US) | 2022-03-01 | — | — | US | claimed |
| WO-2003067989-A1 | ENHANCED ACTIVITY HYDROGEN PEROXIDE DISINFECTANT | VIROX TECHNOLOGIES INC. (CA) | 2003-08-21 | — | — | WO | claimed |
| CN-1117558-C | Compositions containing an antifungal and a sulfur compound | JANSSEN PHARMACEUTICA NV (BE) | 2003-08-13 | — | — | CN | claimed |
| EP-0741519-B1 | USE OF A COMBINATION OF A TERPENE ALCOHOL AND A NON-BACTERICIDAL SURFACTANT AS A BACTERICIDAL MIXTURE, AND RESULTING COMPOSITION | ACTION PIN (FR) | 2000-03-08 | — | — | EP | claimed |
| CN-1242701-A | Compositions contg. antifungal and cationic agent | JANSSEN PHARMACEUTICA NV (BE) | 2000-01-26 | — | — | CN | claimed |
| CN-1242696-A | Composition containing fungicide and phospholipid | JANSSEN PARMACEUTICA N V (BE) | 2000-01-26 | — | — | CN | claimed |
| CN-1231172-A | Powder compositions for making up and/or dermatosis treating using ascorbic acid as main composition | OREAL (FR) | 1999-10-13 | — | — | CN | claimed |
| CN-1211177-A | Compositions containing an antifungal and a sulfur compound | JANSSEN PHARMACEUTICA NV (BE) | 1999-03-17 | — | — | CN | claimed |
| EP-0542526-B1 | Skin cleansing compositions | UNILEVER PLC (GB) | 1997-04-23 | — | — | EP | claimed |
| EP-0271186-B1 | HYDROXYINDOLES AND THEIR USE IN DYEING | REPLIGEN CORPORATION (US) | 1992-12-30 | — | — | EP | claimed |
| EP-0271186-A1 | Hydroxyindoles and their use in dyeing | REPLIGEN CORPORATION (US) | 1988-06-15 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11376209-B2 | Antidandruff composition and method of use | ACR, SMURF1, POLR1C | CA2 4073/4885THRB 3585/4885RECQL 2655/4885 |
| US-11382844-B2 | Shampoo composition and method of use | CUTA, PCNA, ACR | CA2 3556/4885THRB 3281/4885RECQL 2556/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.